Advisor Partners Ii, LLC Charles River Laboratories International, Inc. Transaction History
Advisor Partners Ii, LLC
- $2.47 Billion
- Q3 2023
A detailed history of Advisor Partners Ii, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Advisor Partners Ii, LLC holds 2,393 shares of CRL stock, worth $361,343. This represents 0.02% of its overall portfolio holdings.
Number of Shares
2,393
Previous 2,330
2.7%
Holding current value
$361,343
Previous $489,000
4.29%
% of portfolio
0.02%
Previous 0.02%
Shares
5 transactions
Others Institutions Holding CRL
# of Institutions
648Shares Held
55MCall Options Held
695KPut Options Held
809K-
Vanguard Group Inc Valley Forge, PA6.11MShares$922 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$768 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA4.29MShares$647 Million0.13% of portfolio
-
Ubs Group Ag2.39MShares$361 Million0.07% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.95MShares$294 Million0.75% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $7.68B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...